David Roman
Stock Analyst at Goldman Sachs
(0.47)
# 2407
Out of 5,329 analysts
38
Total ratings
26.32%
Success rate
-0.22%
Average return
Main Sectors:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
TDOC Teladoc Health | Maintains: Buy | 13 10 | 6.99 | 43.06% | 4 | May 1, 2025 | |
GEHC GE HealthCare Techs | Maintains: Buy | 94 82 | 67.71 | 21.1% | 3 | May 1, 2025 | |
KMTS Kestra Medical Techs | Maintains: Neutral | 24 23 | 22.98 | 0.09% | 2 | Apr 16, 2025 | |
HQY HealthEquity | Maintains: Neutral | 107 94 | 88.24 | 6.53% | 2 | Mar 27, 2025 | |
ABT Abbott Laboratories | Maintains: Strong Buy | 138 154 | 131 | 17.56% | 2 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 42 24 | 19.99 | 20.06% | 2 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Sell | 63 71 | 65.72 | 8.03% | 4 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 64 55 | 36.84 | 49.29% | 2 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Buy | 42 | 30.63 | 37.12% | 3 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 91 124 | 108.73 | 14.04% | 2 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 58 80 | 58.11 | 37.67% | 2 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 384 427 | 374.51 | 14.02% | 2 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 81 90 | 75.33 | 19.47% | 3 | Dec 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 90 | 103.16 | -12.76% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 500 | 517.45 | -3.37% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 274 | 169.54 | 61.61% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 129 | 101.89 | 26.61% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Sell | 83 | 83.44 | -0.53% | 1 | May 30, 2024 |